Dregalla Medical Technologies as a Contract Research Organization and Consultancy company focuses on in vitro research and product development for medical device/product-based companies. We assist our clients in securing high-quality data necessary for FDA applications/submission, patent filing and publication in peer-reviewed journals.
In addition, we partner with numerous physician clients to conduct QA/QC assays for autologous cell-derived therapies utilized in orthobiologic-based therapies. For highly motivated and specialized physician clients, we conduct formal research to investigate cellular responses from a variety of cell sources to various stimuli, treatments, and/or scaffolds to improve the quality and consistency of patient outcomes.
Ryan C. Dregalla, Ph.D.
Founder and Chief Scientific Officer
